Literature DB >> 26092969

National Institutes of Health Funding for Tobacco Versus Harm From Tobacco.

John R Hughes1.   

Abstract

INTRODUCTION: Previously, the author documented that, even though tobacco-related diseases accounted for 20% of US deaths, in 1995 the National Institutes of Health (NIH) expended only 1.1% of its budget on tobacco research. The current analysis is a replication test of this result and adds other outcomes and comparisons.
METHODS: The author obtained NIH funding information for tobacco, alcohol, and drug use and for obesity for each year between 2007 and 2014 from Project Reporter and compared these to the total NIH budget and to measures of disease burden.
RESULTS: NIH allocated $321 million for tobacco research in 2014. The percent of the NIH budget dedicated to tobacco was 1.3% in 2014 and has not changed since 1995; similar rates for alcohol, drug, and obesity problems in 2014 were 1.8%, 3.3%, and 3.8%. The ratio of spending to mortality from a risk factor was substantially less for tobacco compared to alcohol or obesity problems (0.07 vs. 0.60 and 0.30).
CONCLUSION: These results replicate our earlier findings. Tobacco research continues to be underfunded at the NIH compared to its disease burden in the United States and to NIH funding for other behavioral risk factors.
© The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26092969      PMCID: PMC5896809          DOI: 10.1093/ntr/ntv137

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  11 in total

1.  Evaluating the burden of disease and spending the research dollars of the National Institutes of Health.

Authors:  H Varmus
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

2.  Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study.

Authors:  M Lamarre-Cliche; A M Castilloux; J LeLorier
Journal:  Clin Invest Med       Date:  2001-04       Impact factor: 0.825

Review 3.  Selected major risk factors and global and regional burden of disease.

Authors:  Majid Ezzati; Alan D Lopez; Anthony Rodgers; Stephen Vander Hoorn; Christopher J L Murray
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

4.  To what extent is health and medical research funding associated with the burden of disease in Australia?

Authors:  S Aoun; D Pennebaker; R Pascal
Journal:  Aust N Z J Public Health       Date:  2004-02       Impact factor: 2.939

Review 5.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

6.  New evidence on the allocation of NIH funds across diseases.

Authors:  Bhaven N Sampat; Kristin Buterbaugh; Marcel Perl
Journal:  Milbank Q       Date:  2013-03       Impact factor: 4.911

7.  A critical view of past NIH research funding on tobacco and nicotine.

Authors:  J R Hughes; A Liguori
Journal:  Nicotine Tob Res       Date:  2000-05       Impact factor: 4.244

8.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

9.  NIH disease funding levels and burden of disease.

Authors:  Leslie A Gillum; Christopher Gouveia; E Ray Dorsey; Mark Pletcher; Colin D Mathers; Charles E McCulloch; S Claiborne Johnston
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

10.  NSFC health research funding and burden of disease in China.

Authors:  Gelin Xu; Zhizhong Zhang; Qiushi Lv; Yun Li; Ruidong Ye; Yunyun Xiong; Yongjun Jiang; Xinfeng Liu
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

View more
  3 in total

1.  National Institutes of Health Funding for Tobacco Control: 2006 and 2016.

Authors:  Ashley L Merianos; Judith S Gordon; Kelsi J Wood; E Melinda Mahabee-Gittens
Journal:  Am J Health Promot       Date:  2018-05-30

2.  NIH Tobacco Research and the Emergence of Tobacco Regulatory Science.

Authors:  Helen I Meissner; Kriti Sharma; Rachel J Mandal; Mary Garcia-Cazarin; Kay L Wanke; Jonathan Moyer; Charlene Liggins
Journal:  Nicotine Tob Res       Date:  2022-03-01       Impact factor: 5.825

3.  The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking.

Authors:  Shaun Yon-Seng Khoo; Gavan P McNally; Kelly J Clemens
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.